Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Aimedis is a private digital health and healthcare IT company building a blockchain-backed medical ecosystem for patients, clinicians, hospitals, and other healthcare stakeholders. The company focuses on secure health data exchange, telemedicine, online prescriptions, AI-enabled health services, and patient-facing digital healthcare workflows rather than therapeutic drug development. Its offerings include a healthcare metaverse product called Aimedis Avalon and a medical-data marketplace called Aimedis DataXChange, positioned around decentralized health records, remote care, and data monetization. Aimedis appears to operate commercially as a health platform company and is best categorized as healthtech rather than biotech or pharma. The company has also promoted Web3, NFT, and metaverse concepts as part of its broader healthcare infrastructure strategy.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Aimedis.